Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal

March 13, 2025
, 5:45 pm

A VPN is an essential component of IT security, whether you’re just starting a business or are already up and running. Most business interactions and transactions happen online and VPN

Beyond the branded products currently sold by Mallinckrodt and Endo, the companies say the combined business will also have a strong foundation in rare and orphan diseases. Generic medicines will be spun out as a separate company.

The post Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal appeared first on MedCity News.

Leave a Replay

Artificial intelligence for predicting interstitial fibrosis and tubular atrophy using diagnostic ultrasound imaging and biomarkers

How the American Cancer Society Is Using LLMs to Accelerate Research

Lantern Unveils Savings Methodology to Increase Transparency for Specialty Care Pricing

Sign up for our Newsletter

HealthGility provides healthcare organizations with a solution for patient protected health information disclosure and confidentiality that reduces workloads and ensures the safe and secure sharing of sensitive data between different providers.

Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal

Leave a Replay

Related Posts

Artificial intelligence for predicting interstitial fibrosis and tubular atrophy using diagnostic ultrasound imaging and biomarkers

How the American Cancer Society Is Using LLMs to Accelerate Research

Lantern Unveils Savings Methodology to Increase Transparency for Specialty Care Pricing

Follow Us

Sign up for our Newsletter

Our Company

Resources

Connect

© All rights reserved

Contact Us